A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function, Nature, vol.390, issue.6656, pp.175-179, 1997. ,
DOI : 10.1038/36593
2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexes, British Journal of Pharmacology, vol.282, issue.2, pp.321-335, 2010. ,
DOI : 10.1111/j.1476-5381.2010.00823.x
Osteoclast-dependent and-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis, Clin Cancer Res, 2011. ,
Clinical considerations for the use of antiresorptive agents in the treatment of metastatic bone disease. Critical reviews in oncology, hematology, vol.80, issue.2, pp.301-313, 2011. ,
double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma, J Clin Oncol, vol.29, issue.9, pp.1125-1132 ,
Critical review on medicinally potent plant species: Gloriosa superba, Fitoterapia, vol.82, issue.3, pp.293-301, 2011. ,
DOI : 10.1016/j.fitote.2010.11.008
The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study, Agri, vol.21, issue.3, pp.95-103, 2009. ,
Thiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug, British Journal of Pharmacology, vol.281, issue.7, 2011. ,
DOI : 10.1111/j.1476-5381.2011.01702.x